D70.1 – Agranulocytosis secondary to cancer chemotherapy
Coding Notes
Active
Billable, valid for HIPAA-covered transactions
Additional
code for adverse effect, if applicable, to identify drug (T45.1X5)
Code Also
underlying neoplasm
GEM Conversion to ICD-9 CM
Fs: 10000
–
Drug induced neutropenia
MDC / MS-DRG Reference
Back Reference of Diagnostic Codes
Agranulocytosis
(chronic) (cyclical) (genetic) (infantile) (periodic) (pernicious)
See also Neutropenia
D70.9
chemotherapy induced
(cancer)
D70.1
Neutropenia, neutropenic
(chronic) (genetic) (idiopathic) (immune) (infantile) (malignant) (pernicious) (splenic)
D70.9
Sibling Codes
Parent Sibling Codes
View in Tabular
| Code | Title |
|---|---|
| D50-D89 | Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism (D50-D89) |
| D70-D77 | Other disorders of blood and blood-forming organs (D70-D77) |
| D70 | Neutropenia |
| D70.1 |
Agranulocytosis secondary to cancer chemotherapy
Use Additional
code for adverse effect, if applicable, to identify drug (T45.1X5)
Code Also
underlying neoplasm
|